Abstract
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory disorder of immune regulation. HLH following hematopoietic progenitor cell transplantation (HSCT) is unusualand the diagnosis may be challenging because diagnostic criteria overlap with common complications after HSCT, such as graft-versus-host disease and infections. We present a patient who developed HLH secondary to Toxoplasma gondii reactivation.
References
1- Komitopoulou A, Goussetis E, Oikonomopoulou C, et al. Toxoplasma gondii: How fatal is it in pediatric allogeneic bone marrow transplantation setting?. Transpl Infect Dis. 2020;22:e13226. https://doi.org/10.1111/ tid.13226.
2 - Sanchez-Petitto G, Holtzman NG, Bukhari A, et al. Toxoplasma-induced hemophagocytic lymphohistiocytosis after haploidentical allogeneic stem cell transplantation. Transpl Infect Dis. 2020;22:e13242. https ://doi.org/10.1111/tid.13242.
3 - Conrad A, Le Marechal M, Dupont D, et al. A matched case–control study of toxoplasmosis after allogeneic haematopoietic stem cell transplantation: still a devastating complication. Clinical Microbiology and Infection. May 09, 2016. https://doi.org/10.1016/j.cmi.2016.04.025.
All material published in the journal HEMATOLOGÍA (electronic and print version) is transferred to the Argentinean Society of Hematology. In accordance with the copyright Act (Act 11 723), a copyright transfer form will be sent to the authors of approved works, which has to be signed by all the authors before its publication. Authors should keep a copy of the original since the journal is not responsible for damages or losses of the material that was submitted. Authors should send an electronic version to the email: revista@sah.org.ar
